Vincerx Pharma (VINC) Earnings Date, Estimates & Call Transcripts $0.30 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Vincerx Pharma Latest Earnings SummaryUpcoming Earnings DateApr. 4EstimatedActual EPS (Aug. 8) -$0.05 Beat By $0.12 Consensus EPS (Aug. 8) -$0.17 Vincerx Pharma posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.05, which topped analysts' consensus estimates of -$0.17 by $0.12. With a trailing EPS of -$1.03, Vincerx Pharma's earnings are expected to grow next year, from ($0.38) to ($0.23) per share. VINC Upcoming EarningsVincerx Pharma's next earnings date is estimated for Friday, April 4, 2025, based off prior year's reporting schedules. Get Vincerx Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vincerx Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVINC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VINC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Golden CrestTrump Can’t Stop This Crisis—Your Savings Are in JeopardyA lot of people are betting on Trump's re-election to solve everything. They think that if he wins, the economy will bounce back, and their retirement will be safe. But here's the cold, hard truth: It's too late for that.Click Here For Your Free Guide Vincerx Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.26-$0.26-$0.26Q2 20241-$0.17-$0.17-$0.17Q3 20241-$0.14-$0.14-$0.14Q4 20241-$0.13-$0.13-$0.13FY 20244($0.70)($0.70)($0.70) Vincerx Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 4/4/2025(Estimated)------- 8/8/2024--$0.17-$0.05+$0.12-$0.05--5/14/2024Q1 2024-$0.26-$0.34 -$0.08-$0.10--3/29/2024Q4 2023--$0.23 -$0.23-$0.23--11/14/2023Q3 2023-$0.49-$0.46+$0.03-$0.46--8/7/2023Q2 2023-$0.65-$0.52+$0.13-$0.52--5/11/2023Q1 2023-$0.69-$0.68+$0.01-$0.68-- Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 3/28/2023Q4 2022-$0.63-$0.65 -$0.02-$0.65-- Vincerx Pharma Earnings - Frequently Asked Questions When is Vincerx Pharma's earnings date? Vincerx Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 4th, 2025 based off last year's report dates. Learn more on VINC's earnings history. Did Vincerx Pharma beat their earnings estimates last quarter? In the previous quarter, Vincerx Pharma (NASDAQ:VINC) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.12. Learn more on analysts' earnings estimate vs. VINC's actual earnings. How much profit does Vincerx Pharma generate each year? Vincerx Pharma (NASDAQ:VINC) has a recorded net income of -$40.16 million. VINC has generated -$1.03 earnings per share over the last four quarters. What is Vincerx Pharma's EPS forecast for next year? Vincerx Pharma's earnings are expected to grow from ($0.38) per share to ($0.23) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies CERo Therapeutics Earnings Results DURECT Earnings Results Lantern Pharma Earnings Results Daré Bioscience Earnings Results CalciMedica Earnings Results Lexaria Bioscience Earnings Results Clene Earnings Results Lumos Pharma Earnings Results BioLineRx Earnings Results Iterum Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run Trump Can’t Stop This Crisis—Your Savings Are in Jeopardy (Ad)A lot of people are betting on Trump's re-election to solve everything. They think that if he wins, the economy will bounce back, and their retirement will be safe. But here's the cold, hard truth: It's too late for that.Click Here For Your Free Guide This page (NASDAQ:VINC) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VINC Stock Alerts